Pharmaceuticals

Rising Osteoporosis Prevalence Driving Growth in the Bone Pain Treatment Market

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Bone Pain Treatment Market At The End Of The 2026–2030 Forecast Period?

The bone pain treatment market has witnessed substantial growth over recent years. This market is projected to expand from $6.05 billion in 2025 to reach $6.5 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion has been driven by factors such as the prevalence of fractures, cancer metastasis to bone, the application of opioid pain management, specialized hospital orthopedic care, and the increasing elderly demographic.

The bone pain treatment market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $8.58 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This projected growth is driven by factors such as opioid regulation, the increase in non-pharmacological therapy growth, the broadening of oncology supportive care expansion, the rise in rehabilitation services growth, and a greater emphasis on chronic pain management focus. Key trends identified for this period encompass the increased use of multimodal pain management, the proliferation of non-opioid pain therapies, the wider expansion of cancer-related bone pain treatment, the adoption of physical and rehabilitative therapies, and a strong focus on personalized pain management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24486&type=smp

What Drivers Are Shaping The Future Growth Of The Bone Pain Treatment Market?

The bone pain treatment market is expected to grow, driven by the increasing prevalence of osteoporosis. This medical condition is characterized by a reduction in bone density and strength, leading to fragile bones that are more prone to fractures. The rise in osteoporosis is linked to the aging global population, as bone density naturally decreases with age, thereby increasing the risk of developing the disease. Bone pain treatment assists in managing osteoporosis by alleviating discomfort and improving mobility, which enhances the overall management of the condition and supports bone health maintenance. For instance, in April 2023, according to the AO Foundation, a Switzerland-based nonprofit organization, osteoporotic fractures occur every three seconds worldwide, impacting about 8.9 million people annually. In the U.S., these injuries already cost the healthcare system around USD 14 billion annually, and this economic burden is projected to more than double by 2025. Therefore, the increasing prevalence of osteoporosis is a key factor driving the growth of the bone pain treatment market.

What Segment Types Make Up The Bone Pain Treatment Market?

The bone pain treatment market covered in this report is segmented –

1) By Treatment Type: Pharmacological Treatments, Non-Pharmacological Treatments, Surgical Interventions

2) By Drug Class: Analgesics, Antidepressants, Anticonvulsants, Corticosteroids

3) By Indication: Injury, Infection, Tumors

4) By Distribution Channel: Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Pharmacological Treatments: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Anticonvulsants, Antidepressants

2) By Non-Pharmacological Treatments: Physical Therapy, Acupuncture, Transcutaneous Electrical Nerve Stimulation

3) By Surgical Interventions: Joint Replacement Surgery, Spinal Fusion, Vertebroplasty And Kyphoplasty, Tumor Resection, Debridement Surgery

Which Market Trends Are Creating New Opportunities In The Bone Pain Treatment Market?

Leading firms in the bone pain treatment market are concentrating on creating novel solutions, such as prescription wearable devices, to provide precise pain alleviation. These medically sanctioned gadgets, worn on the body, administer focused treatments like electrical stimulation or heat. Their purpose is to alleviate bone pain by enhancing blood circulation, reducing inflammation, or inhibiting pain signals. For instance, in May 2025, Osteoboost Health Inc., a US-based medical equipment manufacturer, launched Osteoboost, the inaugural FDA-cleared wearable device specifically developed for individuals with low bone density. This particular wearable belt delivers focused, low-amplitude, high-frequency vibration therapy (20–40 Hz) to the spine and hips, with the objective of decelerating the loss of bone density and strength in postmenopausal women experiencing osteopenia. The device, when used for 30 minutes daily during routine activities, has been clinically demonstrated to assist in mitigating the reduction in bone strength and volumetric bone density, without any notable adverse events being reported. Its design incorporates a motorized vibration pack, a pressure sensor, and accelerometers, ensuring the safe and effective administration of therapy.

Who Are The Key Players Driving Competition In The Bone Pain Treatment Market?

Major companies operating in the bone pain treatment market are AbbVie Inc., Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Perrigo Company plc, Viatris Inc., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Indivior PLC, Pfizer Consumer Healthcare (Haleon), Kyowa Kirin Co. Ltd., Ferring Pharmaceuticals, Chiesi Farmaceutici S.p.A., Bausch Health Companies Inc., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi, Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd.

Read the full bone pain treatment market report here:

https://www.thebusinessresearchcompany.com/report/bone-pain-treatment-global-market-report

Which Geographic Regions Are Influencing Demand In The Bone Pain Treatment Market?

North America was the largest region in the bone pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bone Pain Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24486&type=smp

Browse Through More Reports Similar to the Global Bone Pain Treatment Market 2026, By The Business Research Company

Bone And Joint Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-and-joint-health-supplements-global-market-report

Bone Cancer Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bone-cancer-treatment-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795